Noun:

লেভোডোপা,

levodopa's Usage Examples:

of these drugs is usually taken along with levodopa, often combined with levodopa in the same pill.

l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well.

Entacapone together with levodopa and carbidopa allows levodopa to have a longer effect in the brain and reduces Parkinson's.

methyl ester of levodopa.

It is used in tablet form as an effervescent prodrug with 250 times the water solubility of tablet levodopa.

Etilevodopa Hickey.

peripheral metabolism of levodopa.

This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood–brain.

It is the ethyl ester of levodopa.

Melevodopa Djaldetti R, Giladi N, Hassin-Baer S.

It also methylates levodopa.

COMT inhibitors are indicated for the treatment of Parkinson's disease in combination with levodopa and an aromatic L-amino.

reduced risk for motor complications in Parkinson patients relative to levodopa.

Levodopa-induced dyskinesia (LID) is evident in patients with Parkinson's disease who have been on levodopa (L‑DOPA) for prolonged.

Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa.

d-DOPA (d-3,4-dihydroxyphenylalanine; dextrodopa) is similar to l-DOPA (levodopa), but with opposite chirality.

the brand name Nourianz, is a medication used as an add-on treatment to levodopa/carbidopa in adults with Parkinson's disease (PD) experiencing "off" episodes.

brand name Ongentys, is a medication which is administered together with levodopa in people with Parkinson's disease.

counteracting the dyskinesias associated with long term treatment with levodopa and related drugs.

used in the management of Parkinson's disease in combination with L-DOPA (levodopa) as co-beneldopa (BAN), under the brand names Madopar in the UK and Prolopa.

Choreoathetosis is also a common presentation of dyskinesia as a side effect of levodopa-carbidopa in the treatment of Parkinson disease.

treatment of Parkinson's disease as an adjunct to levodopa/carbidopa or levodopa/benserazide medications.

development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID).

Etilefrine Etilevodopa Ethylnorepinephrine Indanidine Isometheptene L-DOPA (levodopa) L-Phenylalanine L-Tyrosine Melevodopa Metaraminol Methoxamine Methyldopa.